错配人类白细胞抗原-B的间接呈递与脐血移植结局相关
该回顾性研究分析2000至2018年日本8家机构1498例单份脐血移植,用PIRCHE算法评估错配HLA免疫原性。结果显示,来自错配受者HLA-B的I类表位经匹配的HLA I类呈递时与较高移植相关死亡率和较低中性粒细胞植入显著相关,尤其HLA-B外显子1来源表位预后意义更强。
要点
- 错配受者HLA-B来源的I类表位经匹配HLA I类呈递时与较差结局相关。
- HLA-B外显子1来源表位预后意义更强,携带M型前导肽的HLA-B等位基因对其亲和力更高。
- 匹配的M型HLA-B且存在错配HLA-B外显子1来源I类表位的患者结局更差。
核心结论
- 来自错配受者HLA-B的I类表位经匹配HLA I类呈递时与较高移植相关死亡率和较低中性粒细胞植入显著相关。
- HLA-B外显子1来源表位预后意义更强,携带M型前导肽的HLA-B等位基因对其亲和力更高。
- 匹配的M型HLA-B且存在错配HLA-B外显子1来源I类表位的患者结局更差。
- 这些发现提示基于免疫原性的供者选择可能改善脐血移植结局。
研究设计与样本
- 回顾性分析2000年至2018年日本8家机构1498例单份脐血移植病例。
- 使用PIRCHE算法评估错配HLA免疫原性,检查HLA来源表位与供者或受者HLA的结合亲和力。
主要发现
- 来自错配受者HLA-B的I类表位与较高移植相关死亡率和较低中性粒细胞植入显著相关,尤其在匹配HLA I类呈递时。
- HLA-B外显子1来源表位预后意义更强,携带M型前导肽的HLA-B等位基因对这些表位亲和力更高。
- 匹配的M型HLA-B且存在错配HLA-B外显子1来源I类表位的患者结局更差。
临床怎么用
- 作者认为基于免疫原性的供者选择可能改善脐血移植结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cord blood transplantation (CBT) is a valuable donor source for patients without human leukocyte antigen (HLA)-matched donors. While CBT has a lower risk of graft-versus-host disease and requires less stringent histocompatibility, it is associated with a higher transplantation-related mortality (TRM) compared to other donor sources. We hypothesized that assessing the immunogenicity of mismatched HLA could reveal non-permissive mismatches contributing to increased TRM. We retrospectively analysed 1498 single-unit CBT cases from 2000 to 2018 across eight Japanese institutions, evaluating the immunogenicity of mismatched HLA using the PIRCHE algorithm to examine binding affinities of HLA-derived epitopes to donor or recipient HLA. Results indicated that Class I epitopes from mismatched recipient HLA-B were significantly associated with poor outcomes due to higher TRM and lower neutrophil engraftment, particularly when presented on matched HLA class I. Notably, epitopes from HLA-B exon 1 showed stronger prognostic significance, with HLA-B alleles carrying M-type leader peptides exhibiting higher affinity for these epitopes. Patients with a matched M-type HLA-B and Class I epitopes derived from mismatched HLA-B exon 1 had worse outcomes. These findings suggest that immunogenicity-informed donor selection could improve CBT outcomes.
引用
- Sugio T, Miyawaki K, Uchida N, et al. Indirect presentation of mismatched human leukocyte antigen-B associates with outcomes of cord blood transplantation. Br J Haematol. 2025. PMID: 40065633. doi:10.1111/bjh.20035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。